Next Article in Journal
A New Cytotoxicity Assay for Brevetoxins Using Fluorescence Microscopy
Previous Article in Journal
An Improved High Yield Total Synthesis and Cytotoxicity Study of the Marine Alkaloid Neoamphimedine: An ATP-Competitive Inhibitor of Topoisomerase IIα and Potent Anticancer Agent
Open AccessArticle

Purification of a Low Molecular Weight Fucoidan for SPECT Molecular Imaging of Myocardial Infarction

1
Inserm, U1148, LVTS, Paris Diderot University, Bichat-Claude Bernard Hospital, F-75877, Paris, France
2
Galilée Institute, Paris 13 University, Sorbonne Paris Cité, F-93430, Villetaneuse, France
3
Multimodal Imaging Research Federation (FRIM), Paris Diderot University, F-75877, Paris, France
4
Nuclear Medicine Department, Bichat-Claude Bernard Hospital, AP-HP, F-75877, Paris, France
5
Laboratory CSPBAT, Paris 13 University, Sorbonne Paris Cité, CNRS UMR 7244, SBMB team, F-93017, Bobigny, France
6
Laboratory of Polymers Biopolymers Surfaces, Normandie University, Rouen University, F-76821, Mont Saint Aignan, France
7
Laboratory of Polymers Biopolymers Surfaces, CNRS, UMR 6270 and FR3038, F-76821, Mont Saint Aignan, France
8
Algues & Mer, Kernigou, F-29242, Ouessant, France
*
Author to whom correspondence should be addressed.
Mar. Drugs 2014, 12(9), 4851-4867; https://doi.org/10.3390/md12094851
Received: 31 July 2014 / Revised: 5 September 2014 / Accepted: 9 September 2014 / Published: 23 September 2014
Fucoidans constitute a large family of sulfated polysaccharides with several biochemical properties. A commercial fucoidan from brown algae, containing low molecular weight polysaccharidic species constituted of l-fucose, uronic acids and sulfate groups, was simply treated here with calcium acetate solution. This treatment led to a purified fraction with a yield of 45%. The physicochemical characterizations of the purified fucoidan using colorimetric assay, MALLS, dRI, FT-IR, NMR, exhibited molecular weight distributions and chemical profiles similar for both fucoidans whereas the sulfate and l-fucose contents increased by 16% and 71%, respectively. The biodistribution study in rat of both compounds labeled with 99mTc evidenced a predominant renal elimination of the purified fucoidan, but the crude fucoidan was mainly retained in liver and spleen. In rat myocardial ischemia-reperfusion, we then demonstrated the better efficiency of the purified fucoidan. This purified sulfated polysaccharide appears promising for the development of molecular imaging in acute coronary syndrome. View Full-Text
Keywords: fucoidan; molecular imaging; atherothrombosis; SPECT fucoidan; molecular imaging; atherothrombosis; SPECT
Show Figures

Graphical abstract

MDPI and ACS Style

Saboural, P.; Chaubet, F.; Rouzet, F.; Al-Shoukr, F.; Azzouna, R.B.; Bouchemal, N.; Picton, L.; Louedec, L.; Maire, M.; Rolland, L.; Potier, G.; Guludec, D.L.; Letourneur, D.; Chauvierre, C. Purification of a Low Molecular Weight Fucoidan for SPECT Molecular Imaging of Myocardial Infarction. Mar. Drugs 2014, 12, 4851-4867.

AMA Style

Saboural P, Chaubet F, Rouzet F, Al-Shoukr F, Azzouna RB, Bouchemal N, Picton L, Louedec L, Maire M, Rolland L, Potier G, Guludec DL, Letourneur D, Chauvierre C. Purification of a Low Molecular Weight Fucoidan for SPECT Molecular Imaging of Myocardial Infarction. Marine Drugs. 2014; 12(9):4851-4867.

Chicago/Turabian Style

Saboural, Pierre; Chaubet, Frédéric; Rouzet, Francois; Al-Shoukr, Faisal; Azzouna, Rana B.; Bouchemal, Nadia; Picton, Luc; Louedec, Liliane; Maire, Murielle; Rolland, Lydia; Potier, Guy; Guludec, Dominique L.; Letourneur, Didier; Chauvierre, Cédric. 2014. "Purification of a Low Molecular Weight Fucoidan for SPECT Molecular Imaging of Myocardial Infarction" Mar. Drugs 12, no. 9: 4851-4867.

Find Other Styles

Article Access Map by Country/Region

1
Only visits after 24 November 2015 are recorded.
Search more from Scilit
 
Search
Back to TopTop